Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Peds Metabolic Syndrome in Psoriasis

This study has been completed.
Sponsor:
Collaborator:
Amgen
Information provided by (Responsible Party):
Alice Gottlieb, Tufts Medical Center
ClinicalTrials.gov Identifier:
NCT00930592
First received: June 29, 2009
Last updated: September 16, 2013
Last verified: September 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2012
  Primary Completion Date: July 2012 (Final data collection date for primary outcome measure)